Freshpet, Inc. Reports Second Quarter 2025 Financial Results

Rhea-AI Summary

Freshpet (NASDAQ:FRPT) reported strong Q2 2025 financial results with net sales of $264.7 million, up 12.5% year-over-year, driven by volume gains of 10.8% and favorable price/mix of 1.7%. The company achieved net income of $16.4 million, compared to a net loss of $1.7 million in the prior year period.

Key metrics include improved gross margin of 40.9% (up from 39.9%) and Adjusted EBITDA of $44.4 million (up from $35.1 million). Due to challenging consumer sentiment, Freshpet updated its 2025 guidance, now expecting net sales growth of 13-16% (down from 15-18%) and reduced capital expenditures to ~$175 million (from ~$225 million). The company also removed its 2027 $1.8 billion net sales target but maintained its Adjusted Gross Margin target of 48% and Adjusted EBITDA Margin target of 22%.

Positive

• Net income improved to $16.4 million from prior year loss of $1.7 million
• Net sales increased 12.5% to $264.7 million in Q2 2025
• Gross margin improved to 40.9% from 39.9% year-over-year
• Adjusted EBITDA increased to $44.4 million from $35.1 million
• SG&A as percentage of sales decreased significantly by 660 basis points to 34.1%
• Strong cash position with $243.7 million in cash and cash equivalents

Negative

• Removed long-term 2027 net sales target of $1.8 billion due to slower growth
• Reduced 2025 net sales growth guidance to 13-16% from previous 15-18%
• Cash from operations decreased by $9.1 million compared to prior year period
• Net income for first six months of 2025 decreased to $3.7 million from $16.9 million in prior year

Insights

Financial Analyst

Freshpet delivered solid Q2 growth with improved profitability despite consumer headwinds, but lowered sales guidance reflects economic challenges.

Freshpet reported strong Q2 2025 results with 12.5% revenue growth to $264.7 million, primarily driven by volume gains (10.8%) and favorable price/mix (1.7%). The company swung to a $16.4 million profit from a $1.7 million loss in the prior year period, demonstrating improved operational efficiency.

The gross margin improved by 100 basis points to 40.9%, while adjusted gross margin reached 46.9%, up from 45.9%. This margin expansion stems primarily from lower input costs and reduced quality issues, partially offset by decreased leverage on plant expenses. SG&A expenses decreased significantly, falling 6.6% to $90.4 million and representing 34.1% of sales compared to 40.7% in the prior year.

Notably, Freshpet revised its 2025 sales growth guidance downward to 13-16% from 15-18% previously, citing "a more challenging consumer sentiment backdrop." The company also reduced its capital expenditure forecast to $175 million, down $50 million from earlier projections, signaling a more conservative approach to expansion. Perhaps most significantly, management removed its 2027 revenue target of $1.8 billion, acknowledging the need to adjust to current economic conditions.

The balance sheet remains solid with $243.7 million in cash and $396.2 million in debt. Operating cash flow was $38.7 million for the first half of 2025, down $9.1 million year-over-year due to higher variable compensation payments.

While Freshpet continues to outperform the broader dog food category with double-digit growth, the guidance reduction reflects management's pragmatic view of the challenging economic environment. Their focus on operational efficiency and margin expansion appears to be yielding positive results, even as they adapt their long-term growth targets to reflect current market realities.

Delivers Category Leading Growth
Drives Operational Efficiencies that Deliver Margin Expansion and Reduce Capital Requirements
Updates Outlook for 2025 and 2027

BEDMINSTER, N.J., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today reported financial results for its second quarter and six months ended June 30, 2025.

Second Quarter 2025 Financial Highlights Compared to Prior Year Period

• Net sales of $264.7 million, an increase of 12.5%.
• Net income of $16.4 million, compared to the prior year period net loss of $1.7 million.
• Gross margin of 40.9%, compared to the prior year period of 39.9%.
• Adjusted Gross Margin of 46.9%, compared to the prior year period of 45.9%.¹
• Adjusted EBITDA of $44.4 million, compared to the prior year period of $35.1 million.¹
  

"Against a more challenging consumer sentiment backdrop, we continue to significantly outperform the dog food category - delivering both category leading sales growth and strong improvements in operations," commented Billy Cyr, Freshpet’s Chief Executive Officer. “As a nimble growth company that is adapting to an economically constrained consumer, we are intensely focused on what we can control. That includes accelerating our advertising and distribution programs, reducing our capital expenditures, and strengthening our operations. On the other hand, we will be pragmatic about what we can't control, so we are revising our current year's net sales target and removing our long-term net sales target to match the environment we are facing today. We still believe we will deliver outsized growth for a long period of time, but we need to plan for the current economic realities. In total, we believe the actions we are taking position us well to create significant shareholder value and fulfill our mission to elevate the way we feed our pets with fresh food that nourishes all."

Second Quarter 2025

Net sales increased 12.5% to $264.7 million for the second quarter of 2025 compared to $235.3 million in the prior year period. The increase in net sales was primarily driven by volume gains of 10.8% and favorable price/mix of 1.7%.

Gross profit was $108.2 million, or 40.9% as a percentage of net sales, for the second quarter of 2025, compared to $94.0 million, or 39.9% as a percentage of net sales, in the prior year period. The increase in reported gross profit as a percentage of net sales was primarily due to lower input costs and reduced quality costs, partially offset by reduced leverage on plant expenses. For the second quarter of 2025, Adjusted Gross Profit was $124.0 million, or 46.9% as a percentage of net sales, compared to $108.0 million, or 45.9% as a percentage of net sales, in the prior year period.¹

Selling, general and administrative expenses (“SG&A”) were $90.4 million for the second quarter of 2025 compared to $95.7 million in the prior year period. SG&A as a percentage of net sales decreased by 660 basis points to 34.1% for the second quarter of 2025 compared to 40.7% in the prior year period, primarily due to decreased share-based compensation and variable compensation accrual, partially offset by increased media spend as a percentage of net sales. Adjusted SG&A for the second quarter of 2025 was $79.6 million, or 30.1% as a percentage of net sales, compared to $72.9 million, or 31.0% as a percentage of net sales, in the prior year period.¹

Net income was $16.4 million for the second quarter of 2025 compared to net loss of $1.7 million in the prior year period. The increase in net income was due to contribution from higher sales, improved gross profit as a percentage of net sales and decreased SG&A expenses.

Adjusted EBITDA was $44.4 million for the second quarter of 2025 compared to $35.1 million in the prior year period.¹ The increase in Adjusted EBITDA was a result of increased Adjusted Gross Profit, partially offset by higher Adjusted SG&A.

First Six Months of 2025

Net sales increased 15.0% to $527.9 million for the first six months of 2025 compared to $459.1 million in the prior year period. The increase in net sales was primarily driven by volume gains of 12.8% and favorable price/mix of 2.2%.

Gross profit was $212.0 million, or 40.2% as a percentage of net sales, for the first six months of 2025, compared to $182.1 million, or 39.7% as a percentage of net sales, in the prior year period. The increase in reported gross profit as a percentage of net sales was primarily due to lower input costs and reduced quality costs, partially offset by reduced leverage on plant expenses. For the first six months of 2025, Adjusted Gross Profit was $244.3 million, or 46.3% as a percentage of net sales, compared to $209.5 million, or 45.6% as a percentage of net sales, in the prior year period.¹

SG&A were $205.7 million for the first six months of 2025 compared to $175.4 million in the prior year period. SG&A as a percentage of net sales increased by 80 basis points to 39.0% for the first six months of 2025 compared to 38.2% in the prior year period, primarily due to increased media spend as a percentage of net sales and higher non-recurring charges in the first quarter of 2025, partially offset by decreased share-based compensation and variable compensation accrual. Adjusted SG&A for the first six months of 2025 was $164.3 million, or 31.1% as a percentage of net sales, compared to $143.8 million, or 31.3% as a percentage of net sales, in the prior year period.¹

Net income was $3.7 million for the first six months of 2025 compared to net income of $16.9 million in the prior year period. The decrease in net income was due to increased SG&A expenses, including increased media spend of $18.8 million and $16.9 million of non-recurring charges in the first quarter of 2025 compared to a $9.9 million gain on equity investment in the prior year period, which were partially offset by contributions from higher sales and improved gross profit as a percentage of net sales.

Adjusted EBITDA was $79.9 million for the first six months of 2025 compared to $65.7 million in the prior year period.¹ The increase in Adjusted EBITDA was a result of increased Adjusted Gross Profit, partially offset by higher Adjusted SG&A.

Balance Sheet

As of June 30, 2025, the Company had cash and cash equivalents of $243.7 million with $396.2 million of debt outstanding, net of $6.3 million of unamortized debt issuance costs. For the six months ended June 30, 2025, cash from operations was $38.7 million, a decrease of $9.1 million compared to the prior year period driven largely by the higher variable incentive compensation payment in the first quarter of 2025.

The Company will utilize its balance sheet to support its ongoing capital needs in connection with its long-term capacity plan.

Outlook

For full year 2025, the Company is updating its guidance and now expects the following:

• Net sales increase of 13% to 16% from 2024, compared to an increase of 15% to 18% in the previous guidance;
• Adjusted EBITDA in the range of $190 million to $210 million, unchanged; and
• Capital expenditures of ~$175 million, compared to ~$225 million in the previous guidance.
  

The Company is also updating its long-term guidance. For full year 2027, the Company is removing the $1.8 billion net sales target to adjust for the recent slower growth; however, the Company expects to continue to deliver growth significantly in excess of the dog food category. The Company is reiterating its Adjusted Gross Margin target of 48% and Adjusted EBITDA Margin target of 22% for full year 2027.

1. Adjusted Gross Margin, Adjusted Gross Profit, Adjusted SG&A and Adjusted EBITDA are non-GAAP financial measures. See "Non-GAAP Measures" for how the Company defines these measures and the financial tables that accompany this release for reconciliations of these measures to the closest comparable GAAP measures.
   

The Company does not provide guidance for net income (loss), the U.S. GAAP measure most directly comparable to Adjusted EBITDA, and similarly cannot provide a reconciliation between its forecasted Adjusted EBITDA and net income (loss) metrics without unreasonable effort due to the unavailability of reliable estimates for certain components of net income (loss) and the respective reconciliations, including the timing of and amount of costs of goods sold and selling, general and administrative expenses. These items are not within the Company's control and may vary greatly between periods and could significantly impact future results.

Conference Call & Earnings Presentation Webcast Information
As previously announced, today, August 4, 2025, the Company will host a conference call beginning at 8:00 a.m. Eastern Time with members of its leadership team. The conference call webcast will be available live over the Internet through the "Investors" section of the Company's website at www.freshpet.com. To participate on the live call, listeners in North America may dial (877) 407-0792 and international listeners may dial (201) 689-8263; the passcode is 13754861.

About Freshpet

Freshpet's mission is to elevate the way we feed our pets with fresh food that nourishes all. Freshpet foods are blends of fresh meats, vegetables and fruits farmed locally and made at our Freshpet Kitchens. We thoughtfully prepare our foods using natural ingredients, cooking them in small batches at lower temperatures to preserve the natural goodness of the ingredients. Freshpet foods and treats are kept refrigerated from the moment they are made until they arrive at Freshpet Fridges in your local market.

Our foods are available in select grocery, mass, digital, pet specialty, and club retailers across the United States, Canada and Europe, as well as online in the U.S. From the care we take to source our ingredients and make our food, to the moment it reaches your home, our integrity, transparency and social responsibility are the way we like to run our business. To learn more, visit www.freshpet.com.

Connect with Freshpet:

https://www.facebook.com/Freshpet 

https://x.com/Freshpet 

http://instagram.com/Freshpet 

http://pinterest.com/Freshpet 

https://www.tiktok.com/@Freshpet 

https://www.youtube.com/user/freshpet400 

Forward Looking Statements
Certain statements in this press release constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are based on our current expectations and assumptions. These include statements our focus on accelerating our advertising and distribution programs, reducing our capital expenditures, and strengthening our operations, our expectation to grow significantly in excess of the dog food category, updated guidance on 2025 net sales and capital expenditures and our long-term net sales target. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those discussed in the forward-looking statements including difficulties in launching our new technology, a change in economic uncertainty, changes in rates of pet acquisition, the launch of new competitive products, impact of tariffs, difficulties in construction of manufacturing facilities, and most prominently, the risks discussed under the heading "Risk Factors" in the Company's latest annual report on Form 10-K and quarterly reports on Form 10-Q filled with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this presentation. Freshpet undertakes no obligation to publicly update or revise any forward-looking statement because of new information, future events or otherwise, except as otherwise required by law. If we do update one or more forward-looking statements, no inference should be made that we will make additional updates with respect to those or other forward-looking statements.

Non-GAAP Financial Measures

Freshpet uses the following non-GAAP financial measures in its financial communications. These non-GAAP financial measures should be considered as supplements to the U.S. GAAP reported measures, should not be considered replacements for, or superior to, the U.S. GAAP measures and may not be comparable to similarly named measures used by other companies.

• Adjusted Gross Profit
• Adjusted Gross Profit as a percentage of net sales (Adjusted Gross Margin)
• Adjusted SG&A Expenses
• Adjusted SG&A Expenses as a percentage of net sales
• EBITDA
• Adjusted EBITDA
• Adjusted EBITDA as a percentage of net sales (Adjusted EBITDA Margin)
  

Adjusted Gross Profit: Freshpet defines Adjusted Gross Profit as gross profit before depreciation expense, non-cash share-based compensation and loss on disposal of manufacturing equipment.

Adjusted SG&A Expenses: Freshpet defines Adjusted SG&A as SG&A expenses before depreciation and amortization expense, non-cash share-based compensation, loss on disposal of equipment, distributor transition costs, legal obligation and international business changes.

EBITDA and Adjusted EBITDA: EBITDA represents net income (loss) plus interest expense net of interest income, income tax expense and depreciation and amortization expense, and Adjusted EBITDA represents EBITDA less gain on equity investment, plus non-cash share-based compensation expense, loss on disposal of property, plant and equipment, distributor transition costs, legal obligation, and international business changes.

Management believes that the non-GAAP financial measures are meaningful to investors because they provide a view of the Company with respect to ongoing operating results. The non-GAAP financial measures are shown as supplemental disclosures in this release because they are widely used by the investment community for analysis and comparative evaluation. They also provide additional metrics to evaluate the Company’s operations and, when considered with both the Company’s GAAP results and the reconciliation to the most comparable U.S. GAAP measures, provide a more complete understanding of the Company’s business than could be obtained absent this disclosure. The non-GAAP measures are not and should not be considered an alternative to the most comparable U.S. GAAP measures or any other figure calculated in accordance with U.S. GAAP, or as an indicator of operating performance. The Company’s calculation of the non-GAAP financial measures may differ from methods used by other companies. Management believes that the non-GAAP measures are important to an understanding of the Company's overall operating results in the periods presented. The non-GAAP financial measures are not recognized in accordance with U.S. GAAP and should not be viewed as an alternative to U.S. GAAP measures of performance.

FRESHPET, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, in thousands, except per share data)
	June 30, 2025				December 31, 2024
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	243,684			$	268,633
Accounts receivable, net of allowance for doubtful accounts		60,375				68,419
Inventories, net		90,583				80,794
Prepaid expenses		10,702				16,026
Other current assets		3,833				3,126
Total Current Assets		409,177				436,998
Property, plant and equipment, net		1,101,367				1,065,869
Deposits on equipment		450				1,047
Operating lease right of use assets		67,505				3,366
Long term investment in equity securities		33,446				33,446
Other assets		35,549				34,152
Total Assets	$	1,647,494			$	1,574,878
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable	$	42,817			$	39,164
Accrued expenses		37,872				56,263
Current operating lease liabilities		2,074				1,322
Current finance lease liabilities		2,218				2,120
Total Current Liabilities	$	84,981			$	98,869
Convertible senior notes		396,237				395,163
Long term operating lease liabilities		65,655				2,213
Long term finance lease liabilities		28,967				23,273
Total Liabilities	$	575,840			$	519,518
Commitments and contingencies		—				—
STOCKHOLDERS' EQUITY:
Common stock — voting, $0.001 par value, 200,000 shares authorized, 48,792 issued and 48,778 outstanding on June 30, 2025, and 48,716 issued and 48,702 outstanding on December 31, 2024		49				49
Additional paid-in capital		1,350,344				1,338,160
Accumulated deficit		(278,147	)			(281,806	)
Accumulated other comprehensive loss		(336	)			(787	)
Treasury stock, at cost — 14 shares on June 30, 2025 and on December 31, 2024		(256	)			(256	)
Total Stockholders' Equity		1,071,654				1,055,360
Total Liabilities and Stockholders' Equity	$	1,647,494			$	1,574,878

FRESHPET, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited in thousands, except per share data)
	For the Three Months Ended June 30,								For the Six Months Ended June 30,
		2025				2024				2025				2024
NET SALES	$	264,689			$	235,253			$	527,938			$	459,102
COST OF GOODS SOLD		156,499				141,301				315,960				276,992
GROSS PROFIT		108,190				93,952				211,978				182,110
SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES		90,386				95,702				205,671				175,396
INCOME (LOSS) FROM OPERATIONS		17,804				(1,750	)			6,307				6,714
OTHER (EXPENSES) INCOME:
Interest and Other Income, net		2,199				2,861				4,592				6,195
Interest Expense		(3,749	)			(2,751	)			(7,208	)			(5,811	)
Gain on Equity Investment		—				—				—				9,918
		(1,550	)			110				(2,616	)			10,302
INCOME (LOSS) BEFORE INCOME TAXES		16,254				(1,640	)			3,691				17,016
INCOME TAX (BENEFIT) EXPENSE		(102	)			54				32				108
INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS	$	16,356			$	(1,694	)		$	3,659			$	16,908
OTHER COMPREHENSIVE INCOME (LOSS):
Change in foreign currency translation	$	240			$	(79	)		$	451			$	(197	)
TOTAL OTHER COMPREHENSIVE INCOME (LOSS)		240				(79	)			451				(197	)
TOTAL COMPREHENSIVE INCOME (LOSS)	$	16,596			$	(1,773	)		$	4,110			$	16,711
NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS
-BASIC	$	0.34			$	(0.03	)		$	0.08			$	0.35
-DILUTED	$	0.33			$	(0.03	)		$	0.07			$	0.34
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING
-BASIC		48,778				48,461				48,755				48,400
-DILUTED		50,198				48,461				50,256				50,154

FRESHPET, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited, in thousands)
	For the Six Months Ended June 30,
		2025				2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	3,659			$	16,908
Adjustments to reconcile net income to net cash flows provided by operating activities:
Provision for loss on accounts receivable		11,452				13
Loss on disposal of property, plant and equipment		1,229				286
Share-based compensation		15,037				25,755
Inventory obsolescence		—				699
Depreciation and amortization		42,436				33,324
Amortization of deferred financing costs		1,074				1,035
Change in operating lease right of use asset		727				766
Gain on equity investment		—				(9,918	)
Changes in operating assets and liabilities:
Accounts receivable		(3,208	)			(11,407	)
Inventories		(9,400	)			(8,685	)
Prepaid expenses and other current assets		(3,913	)			(3,968	)
Other assets		(3,060	)			(1,240	)
Accounts payable		2,291				(981	)
Accrued expenses		(18,958	)			6,069
Operating lease liability		(673	)			(837	)
Net cash flows provided by operating activities		38,693				47,819
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisitions of property, plant and equipment, software and deposits on equipment		(59,932	)			(94,795	)
Net cash flows used in investing activities		(59,932	)			(94,795	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Tax withholdings related to net shares settlements of restricted stock units		(2,860	)			(1,440	)
Principal payments under finance lease obligations		(1,037	)			(952	)
Proceeds from exercise of options to purchase common stock		187				4,196
Net cash flows (used in) provided by financing activities		(3,710	)			1,804
NET CHANGE IN CASH AND CASH EQUIVALENTS		(24,949	)			(45,172	)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR		268,633				296,871
CASH AND CASH EQUIVALENTS, END OF PERIOD	$	243,684			$	251,699

FRESHPET, INC. AND SUBSIDIARIES RECONCILIATION BETWEEN GROSS PROFIT AND ADJUSTED GROSS PROFIT
	For the Three Months Ended June 30,								For the Six Months Ended June 30,
		2025				2024				2025				2024
	(Dollars in thousands)
Gross profit	$	108,190			$	93,952			$	211,978			$	182,110
Depreciation expense		13,729				11,827				28,909				22,502
Non-cash share-based compensation		1,831				2,220				3,114				4,841
Loss on disposal of manufacturing equipment		260				32				255				53
Adjusted Gross Profit	$	124,010			$	108,031			$	244,256			$	209,506
Adjusted Gross Profit as a % of Net Sales		46.9	%			45.9	%			46.3	%			45.6	%

FRESHPET, INC. AND SUBSIDIARIES RECONCILIATION BETWEEN SG&A EXPENSES AND ADJUSTED SG&A EXPENSES
	For the Three Months Ended June 30,								For the Six Months Ended June 30,
		2025				2024				2025				2024
	(Dollars in thousands)
SG&A expenses	$	90,386			$	95,702			$	205,671			$	175,396
Depreciation and amortization expense		6,167				5,385				12,104				10,455
Non-cash share-based compensation (a)		4,390				17,313				11,923				20,913
Loss on disposal of equipment		225				104				391				233
Distributor transition costs (b)		—				—				10,680				—
Legal obligation (c)		—				—				4,987				—
International business charges (d)		—				—				1,273				—
Adjusted SG&A Expenses	$	79,604			$	72,900			$	164,313			$	143,795
Adjusted SG&A Expenses as a % of Net Sales		30.1	%			31.0	%			31.1	%			31.3	%

(a)	Includes true-ups to share-based compensation expense. We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA margins, Adjusted EBITDA and/or Net Sales targets as a condition of vesting. At each reporting period, we reassess the probability of achieving the performance criteria and the performance period required to meet those targets. When the probability of achieving such performance conditions changes, the compensation cost previously recorded is adjusted as needed. When such performance conditions are deemed to be improbable of achievement, the compensation cost previously recorded is reversed.
(b)	Represents a non-recurring loss as a result of an accounts receivable write-off in connection with the liquidation of one of our pet specialty distributors. Concurrent with its liquidation, we transitioned to a new distribution partner, who is a leading pet specialty distributor and who we anticipate will facilitate sales to pet specialty stores. Thus, despite the transitory impact during the first quarter of 2025, our ability to continue to generate sales is consistent with what we would expect to generate within the pet specialty channel.
(c)	Represents an accrual for legal obligations related to the ongoing litigation with Phillips.
(d)	Represents termination costs due to a business change in our international go-to-market strategy.

FRESHPET, INC. AND SUBSIDIARIES
RECONCILIATION BETWEEN NET INCOME (LOSS) AND ADJUSTED EBITDA

	For the Three Months Ended June 30,								For the Six Months Ended June 30,
		2025				2024				2025				2024
	(Dollars in thousands)
Net income (loss)	$	16,356			$	(1,694	)		$	3,659			$	16,908
Depreciation and amortization		19,896				17,212				41,013				32,957
Interest expense, net of interest income		1,546				(110	)			2,610				(384	)
Income tax (benefit) expense		(102	)			54				32				108
EBITDA		37,696				15,462				47,314				49,589
Non-cash share-based compensation (a)		6,221				19,533				15,037				25,755
Loss on disposal of property, plant and equipment		485				136				646				286
Distributor transition costs (b)		—				—				10,680				—
Legal obligation (c)		—				—				4,987				—
International business charges (d)		—				—				1,273				—
Gain on equity investment		—				—				—				(9,918	)
Adjusted EBITDA	$	44,402			$	35,131			$	79,937			$	65,712
Adjusted EBITDA as a % of Net Sales		16.8	%			14.9	%			15.1	%			14.3	%

(a)	Includes true-ups to share-based compensation expense. We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA margins, Adjusted EBITDA and/or Net Sales targets as a condition of vesting. At each reporting period, we reassess the probability of achieving the performance criteria and the performance period required to meet those targets. When the probability of achieving such performance conditions changes, the compensation cost previously recorded is adjusted as needed. When such performance conditions are deemed to be improbable of achievement, the compensation cost previously recorded is reversed.
(b)	Represents a non-recurring loss as a result of an accounts receivable write-off in connection with the liquidation of one of our pet specialty distributors. Concurrent with its liquidation, we transitioned to a new distribution partner, who is a leading pet specialty distributor and who we anticipate will facilitate sales to pet specialty stores. Thus, despite the transitory impact during the first quarter of 2025, our ability to continue to generate sales is consistent with what we would expect to generate within the pet specialty channel.
(c)	Represents an accrual for legal obligations related to the ongoing litigation with Phillips.
(d)	Represents termination costs due to a business change in our international go-to-market strategy.

Investor Contact:
Rachel Ulsh
Rulsh@freshpet.com 

Media Contact:
Press@freshpet.com

FAQ

What were Freshpet's (FRPT) Q2 2025 earnings results?

Freshpet reported Q2 2025 net sales of $264.7 million (up 12.5%), net income of $16.4 million, and Adjusted EBITDA of $44.4 million. Gross margin improved to 40.9% from 39.9% year-over-year.

Why did Freshpet (FRPT) revise its 2025 guidance?

Due to challenging consumer sentiment, Freshpet lowered its 2025 net sales growth guidance to 13-16% from previous 15-18% and reduced capital expenditure guidance to ~$175 million from ~$225 million.

What is Freshpet's (FRPT) current cash and debt position?

As of June 30, 2025, Freshpet had $243.7 million in cash and cash equivalents with $396.2 million of debt outstanding, net of $6.3 million of unamortized debt issuance costs.

What happened to Freshpet's (FRPT) 2027 financial targets?

Freshpet removed its $1.8 billion net sales target for 2027 due to slower growth, but maintained its Adjusted Gross Margin target of 48% and Adjusted EBITDA Margin target of 22%.

How did Freshpet's (FRPT) operating expenses perform in Q2 2025?

SG&A expenses decreased to 34.1% of net sales, down 660 basis points from 40.7% in the prior year period, primarily due to decreased share-based compensation and variable compensation accrual.